Silverleafe Capital Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History

Silverleafe Capital Partners’s Portfolio XLV Stock Details XLV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-57,217	Closed	-$7.71M	–	103
2025 Q2	$7.71M	Sell	57,217 -20,069	-26%	-$2.71M	2.69%	15
2025 Q1	$11.3M	Sell	77,286 -2,194	-3%	-$319K	3.88%	8
2024 Q4	$10.9M	Buy	79,480 +13,061	+20%	+$1.91M	3.47%	9
2024 Q3	$10.2M	Buy	66,419 +1,440	+2%	+$218K	3.55%	9
2024 Q2	$9.47M	Buy	64,979 +11,442	+21%	+$1.64M	3.24%	9
2024 Q1	$7.91M	Buy	53,537 +16,180	+43%	+$2.32M	3.16%	10
2023 Q4	$5.09M	Buy	37,357 +34	+0.1%	+$4.42K	2.41%	14
2023 Q3	$4.8M	Buy	37,323 +3,604	+11%	+$478K	2.46%	14
2023 Q2	$4.48M	Buy	33,719 +677	+2%	+$89.2K	2.78%	13
2023 Q1	$4.28M	Sell	33,042 -1,074	-3%	-$140K	2.76%	13
2022 Q4	$4.63M	Sell	34,116 -5	-0%	-$663	3.06%	13
2022 Q3	$4.13M	Buy	34,121 +8,650	+34%	+$1.11M	2.65%	12
2022 Q2	$3.27M	Buy	25,471 +224	+0.9%	+$29.4K	1.94%	19
2022 Q1	$3.46M	Sell	25,247 -308	-1%	-$40.8K	1.55%	22
2021 Q4	$3.6M	Sell	25,555 -157	-0.6%	-$20.8K	1.29%	29
2021 Q3	$3.27M	Buy	25,712 +2,031	+9%	+$268K	1.28%	28
2021 Q2	$2.98M	Sell	23,681 -276	-1%	-$33.8K	1.15%	30
2021 Q1	$2.8M	Buy	23,957 +646	+3%	+$74.6K	1.14%	29
2020 Q4	$2.64M	Sell	23,311 -373	-2%	-$40.7K	1.2%	30
2020 Q3	$2.5M	Sell	23,684 -11,523	-33%	-$1.21M	1.27%	28
2020 Q2	$3.52M	Buy	35,207 +1,909	+6%	+$188K	2.41%	15
2020 Q1	$2.95M	Sell	33,298 -1,841	-5%	-$179K	3.52%	12
2019 Q4	$3.58M	Sell	35,139 -260	-0.7%	-$25K	2.02%	17
2019 Q3	$3.19M	Buy	35,399 +305	+0.9%	+$27.8K	2.1%	18
2019 Q2	$3.25M	Sell	35,094 -50	-0.1%	-$4.5K	1.95%	15
2019 Q1	$3.23M	Sell	35,144 -5,635	-14%	-$508K	1.91%	15
2018 Q4	$3.53M	Buy	40,779 +1,703	+4%	+$154K	2.42%	14
2018 Q3	$3.72M	Sell	39,076 -1,401	-3%	-$127K	2.27%	14
2018 Q2	$3.38M	Sell	40,477 -2,391	-6%	-$198K	2.12%	16
2018 Q1	$3.49M	Sell	42,868 -607	-1%	-$51.7K	2.31%	14
2017 Q4	$3.59M	Buy	+43,475	New	+$3.58M	2.41%	14

Other funds holding XLV

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

NAM

Nissay Asset Management Tokyo, Japan $18.9B AUM 27.21% 1-Year Est. Return

Silverleafe Capital Partners's XLV Position: Q3 2025 in Review

Silverleafe Capital Partners sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q3 2025, closing a stake of 57,217 shares — an estimated $7.71M sold.

Silverleafe Capital Partners first reported a position in XLV in Q4 2017 and held it in 31 quarters. The position peaked at $11.3M in Q1 2025. 1,647 funds tracked by Wall St. Rank hold XLV as of Q3 2025.

Silverleafe Capital Partners reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q3 2025 after selling out during the quarter.
Silverleafe Capital Partners sold 57,217 State Street Health Care Select Sector SPDR ETF shares in Q3 2025, an estimated $7.71M.
Silverleafe Capital Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q4 2017 and held it in 31 quarters.
Silverleafe Capital Partners's State Street Health Care Select Sector SPDR ETF position peaked at $11.3M in Q1 2025.
1,647 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2025.

Based on Silverleafe Capital Partners's 13F filing for Q3 2025, filed 16 Oct 2025.